Tevogen Bio Holdings Inc.TVGNNASDAQ

Revenue (LTM)

Net Income (LTM)

$-10M

+83.3% YoY

Free Cash Flow

$-12M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0
Gross Profit	0	0	-0	-0↓6.7%
Operating Income	-5	-1↑79.4%	-9↓827.8%	-54↓505.7%
Net Income	-16	4↑128.3%	-60↓1471.9%	-10↑83.3%
EBITDA	-15	4↑129.4%	-59↓1435.9%	-13↑77.7%
EPS Diluted	-16.50	1.83↑111.1%	-0.02↓101.1%	-4.68↓23300.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	7	5↓23.0%	1↓80.8%	1↑21.9%
Total Current Assets	7	6↓18.6%	2↓70.5%	2↑37.0%
Total Assets	8	8↑1.1%	6↓28.9%	3↓37.1%
Total Current Liabilities	1	2↑193.5%	85↑4260.1%	9↓89.4%
Total Liabilities	24	42↑72.7%	100↑139.7%	10↓89.9%
Total Equity	-16	-34↓105.9%	-94↓178.1%	-7↑92.9%
Total Debt	23	40↑70.4%	95↑138.5%	3↓97.0%
Net Debt	16	35↑111.0%	94↑173.3%	2↓98.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-5	-9↓64.1%	-8↑5.6%	-12↓46.8%
Capital Expenditure	-0	-0↓336.6%	-0↑72.2%	0
Free Cash Flow	-5	-9↓69.6%	-8↑9.1%	-12↓44.5%
Stock-Based Comp	1	5↑686.2%	0	41
Net Change in Cash	7	-2↓123.0%	-4↓171.1%	0↑105.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance